What is the new playbook for pharma insights in the AI era? To find out, Peter Cunningham, CEO and executives from Branding Science sat down with 10 of their counterparts from some of the world’s leading pharmaceutical and biotech companies.
With remits spanning insights, market access, and country-level P&L management across the US, Europe, and beyond, the 10 interviewees collectively represented senior decision-making authority across nearly every critical function in pharma commercial strategy. From this panel, we wanted to get a “front row view” of the emerging challenges and best practices in insights and strategy groups for the AI era. This free Executive Summary report encapsulates the perspectives they offered and outlines the five new missions of Insights leaders in the age of AI.
Get the report